Qiming U.S. Ventures Management, LLC Hille Vax, Inc. Transaction History
Qiming U.S. Ventures Management, LLC
- $1.62 Million
- Q2 2025
A detailed history of Qiming U.S. Ventures Management, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Qiming U.S. Ventures Management, LLC holds 372,615 shares of HLVX stock, worth $775,039. This represents 45.66% of its overall portfolio holdings.
Number of Shares
372,615
Previous 372,615
-0.0%
Holding current value
$775,039
Previous $540,000
37.22%
% of portfolio
45.66%
Previous 53.25%
Shares
2 transactions
Others Institutions Holding HLVX
# of Institutions
74Shares Held
36.1MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$22.1 Million1.11% of portfolio
-
Tang Capital Management LLC San Diego, CA4.92MShares$10.2 Million0.59% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2.42MShares$5.03 Million0.41% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$4.35 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.95MShares$4.06 Million0.0% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $69.5M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.